miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1

57Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: To investigate the roles of miR-34a in progression and chemoresistance of glioma cells. Results: Quantitative real-time PCR analysis showed that miR-34a level was lower, but PD-L1 expression level was higher in glioma tissue specimens compared with normal brain tissues and their expression levels were negatively correlated. Ectopic expression of miR-34a inhibited glioma cell proliferation, promoted cell cycle arrest in G1/S phase and cell apoptosis. Additionally, miR-34a/PD-L1 axis was again confirmed and co-expression of PD-L1 with miR-34a mimics attenuated the effects of miR-34a on cell proliferation and apoptosis in glioma cells. Importantly, PD-L1 overexpression resulted in chemoresistance in glioma cells, this effect was attenuated by miR-34a overexpression. Conclusions: miR-34a inhibits glioma cells progression and chemoresistance via targeting PD-L1.

Cite

CITATION STYLE

APA

Wang, Y., & Wang, L. (2017). miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1. Biotechnology Letters, 39(10), 1485–1492. https://doi.org/10.1007/s10529-017-2397-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free